Логин: Пароль: ?
 
Продукты питания Ткань, одежда, обувь, постельное белье, текстиль Строительные материалы Бумага, пластик, промтовары Биотопливо Продукция для сельского хозяйства, зоотовары Косметика, средства гигиены Медицинские товары и препараты, лекарства Иное

 

Наши партнеры:

 

Новости/Аналитика

Canadian-Spanish Alliance Launches Cannabigerol on Maple Leaf Countries

26.06.2020

In the hemp plant, there are about 500 elements with significant therapeutic potential. If foreign companies focused on the extraction of specifically taken cannabinoids or other plant elements that have significant therapeutic potential, then why therapeutic hemp varieties available in our country cannot become the basis for the specialization of Ukrainian companies in this market related to the use of the “ensemble effect” . 

The pages of the profile electronic publication of Ukrainian hemp breeders have already described " How the Swiss enter the US market with a variety of rich cannabigerol ." The information below refers to the mechanisms by which the aforementioned drug-free cannabinoid appears in Canada.

A Canadian hemp biotechnology company enters into an agreement with a Spanish company for the production and distribution of high cannabigerol (CBG) varieties in the "maple leaf country". The partnership of Cannabis Orchards with Hemp Trading to market the cannabis variety rich in KBG called Panakeia to the Canadian market is taking place after the company began to market it in the United States.

According to the above enterprises, the content of KBG in "Panakeia" is about 18%. It is positioned that one of the alleged benefits of "Panakeia" is that the "green mass" of this variety eliminates immune diseases. 

Representatives of the companies Cannabis Orchards and Hemp Trading declare that the Panakeia variety rich in cannabigerol are planning to register in the appropriate lists of approved varieties for distribution in Canada by the fall of 2020 and to provide leaves and inflorescences of the plant to representatives of the Ministry of Health of the country for conducting relevant studies .

At the moment, Panakeia breeding agreements in the USA are concluded with the American companies “Front Range Biosciences” and “Tesoro Genetics”.

Commentary by the Ukrainian Technical Hemp Association

Hemp Trading developed a cannaberol-rich hemp variety in collaboration with the Polytechnic University of Valencia (Spain).

It is a fact that cannabis varieties rich in drug-free cannabinoids, primarily cannabegerol by European hemp companies, are introduced to the US and Canadian markets. From the foregoing, the following conclusions can be drawn:

1. In Canada, as well as in the USA, most likely there are currently no companies that have achieved significant success in terms of creating cannabis varieties rich in cannabinoids other than cannabidiol and tetrahydrocannabinol;

2. Understanding the rather fierce competition in the global hemp market, companies from Switzerland and at least Spain have focused on creating cannaberol-rich hemp varieties.

3. Available information allows us to conclude that a number of companies in the EU countries are working not only on the creation of hemp plant varieties rich in other non-drug cannabinoids, but on terpenes, finols, flavonoids, as well as other plant elements with significant therapeutic effect.

The above once again indicates that not only and not so much cannabidiol is a panacea for the treatment of all diseases. In the hemp plant, there are about 500 elements with significant therapeutic potential. If foreign companies focused on the extraction of specifically taken cannabinoids or other plant elements that have significant therapeutic potential, then why therapeutic hemp varieties available in our country cannot become the basis for the specialization of Ukrainian companies in this market related to the use of the “ensemble effect” . At least the joint research conducted by Harvard Medical School and the Massachusetts Institute of Technology comparing the effectiveness of the therapeutic properties of extracts of individual cannabinoids with extracts of a full spectrum, as well as non-extracted plant materials containing dozens of hemp plant elements with huge therapeutic properties, confirms the prospects of this business line .

Обучение в рамках "Конопляного Университета"
15.09.2020

Объявления
Все объявления »
 
 

facebook

telegram

twitter